• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

3v.org

Venture Capital Matters

  • Pitch a Startup
    • Make a Contribution
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

Landos Biopharma Completes $60 Million Series B Financing

August 13, 2019 By admin Leave a Comment

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases, announced the successful completion of its $60 million Series B financing round. The financing was co-led by RTW Investments and Perceptive Advisors (Perceptive Xontogeny Venture Fund and Perceptive Life Sciences Fund), and joined by additional new investors, including Osage University Partners and PBM Capital.

Landos Biopharma has closed a $60M Series B co-led by RTW Investments and Perceptive Advisors. These funds will fuel Phase 2 development of BT-11 for #UC and #Crohns as well as advance additional candidates to treat #autoimmune diseases. #IBD

Tweet this
“I am delighted to announce the closing of a $60 million Series B financing,” said Dr. Josep Bassaganya-Riera, Chairman of the Board, President, and CEO of Landos. “This financing is an important part of our strategy to advance lead product BT-11 into global Phase 2 clinical trials for ulcerative colitis and Crohn’s disease. There is an unmet clinical need for new therapies for complex diseases such as Inflammatory Bowel Disease. We are pleased that our investors share Landos’ mission of accelerating drug development and serving the unmet needs of millions of patients living with these widespread and debilitating conditions.”

This financing will support Landos’ Phase 2 global clinical trials for BT-11 in ulcerative colitis and Crohn’s disease. BT-11 is a first-in-class, oral, gut-restricted small molecule therapeutic with a unique mechanism of action that targets a novel pathway called Lanthionine Synthetase C-Like 2 (LANCL2). Results from Landos’ Phase 1 clinical trial (published in May 2019 in the IBD Journal) demonstrated that the compound was well-tolerated. Fecal calprotectin levels, which we believe is a predictive biomarker of response to treatment in IBD, were lower in all BT-11-treated groups when compared to placebo. We believe this activity provides initial biomarker evidence of response to treatment.

“We believe BT-11’s mechanism of action is differentiated with the potential to transform the current treatment paradigm for patients with ulcerative colitis and Crohn’s disease,” said Rod Wong, M.D., managing partner at RTW Investments and new member of the Landos Board of Directors. “RTW is excited to support Landos as it continues its growth trajectory as a business and advances the science driving BT-11.”

“We believe there is tremendous commercial potential for an oral compound for IBD and BT-11 is the most promising candidate we’ve seen at this stage of development,” commented Chris Garabedian, Portfolio Manager, Perceptive Xontogeny Venture Fund. “As an investor in the Series A, we are impressed with the productivity and efficiency of the Landos team in completing a comprehensive preclinical program, securing two open INDs, and successfully generating Phase 1 clinical results in less than two years, and are prepared to move forward with two global Phase 2 studies in ulcerative colitis and Crohn’s disease.” Chris Garabedian will continue to serve on Landos Biopharma’s Board of Directors and will be joined by Konstantin Poukalov of Perceptive Advisors.

About Landos Biopharma
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos’ lead clinical asset, BT-11, is a first-in-class, oral therapeutic that acts locally in the gastrointestinal tract for treatment of inflammatory bowel disease (IBD). The company has completed Phase 1 clinical testing and has initiated Phase 2 clinical testing of BT-11 for inflammatory bowel disease in 2019. Landos also has a robust pipeline of new compounds for other autoimmune diseases, several of which Landos anticipates will advance to IND and Phase 1 clinical testing in 2020. Landos is headquartered in Blacksburg, VA. For more information, please visit www.landosbiopharma.com

Filed Under: PR

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

2021 Was the Year of Container
AIML-powered trading is the future
Demand for refurbished containers is insatiable
Critical Mineral Shortages Could Disrupt Global Supply Chains
Google is working hard to match Apple’s ecosystem integrations
The Pentagon’s FY2023 budget request for hypersonic-related research is $4.7 billion
Open Source eCommerce as a Viable Alternative

Market Research Media

SyntheticMetadata.com (Synthetic Metadata): Synthetic data will reduce personal customer data collection
Voice-Games.com: The Future of Smart Speakers
ResilientSupplies.com: Resilient Supplies, the Name of the Game for the Global Supply Chain
Gaming-Disorder.com: Gaming disorder is now recognised by the World Health Organisation
SetupMarketplace.com: Setup Marketplace
A six-step forecasting methodology
There will be three to four million product managers globally by 2025

Secondary Sidebar

Technologies

Technology sector jumped to a market value of over $13 trillion during the pandemic
Apple Unveils M1 Ultra, the World’s Most Powerful Chip for a Personal Computer
Samsung Electronics and Red Hat Announce Collaboration in the Field of Next-Generation Memory Software
BAE Systems to Bring Next-Generation Electric Drive System to Heavy-Duty Industrial Vehicle Market
Nature Co-design Technologies

Tech Events

DevOps World, September 28-30, 2021, virtual and free
AI Week 2022: Call for Talks, February 7-9 2022, Tel Aviv University
Connect 2021 EMEA, 7-8 December, 2021
Scylla Summit 2022, February 9-10, 2022
IEEE International Conference on Quantum Computing and Engineering, 18-23 September 2022, Broomfield, Colorado

Footer

Recent Posts

  • How to achieving gender balance in management teams
  • When you feel like you’re spiraling
  • After Successful Tax Season, Embedded Tax Platform April Raises $30M Series A from Fintech Veterans
  • Vita Mojo Raises US$30 Million to Help Restaurant and Hospitality Chains in Europe Tackle the Digital Future
  • Nautical Commerce Raises $30M to Scale Multi-Vendor Marketplace Technology
  • Token Announces $13 Million Series B Funding Round and Appointment of New CEO to Disrupt the Authentication Market
  • Konnecto Raises $21M to establish a new category in marketing technology
  • Sharebite, the Leading Food Benefits Platform, Announces Closing of $39 Million Series B Round
  • Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
  • Biotech companies have received significant VC funding in the past three years

Dossier

Gene Pool Technologies Files Patent Infringement Actions Against Halo Collective Subsidiaries Coastal Harvest and ANM
Accenture to Acquire umlaut
The Global Top 100 public companies have reached a total market capitalisation of US$35.2 trillion
Qualcomm to Acquire NUVIA
There is a progress in discussions on a potential price cap on Russian oil

Press Media Release

ADL Says Buffalo Shooter Latest in A Long Line of White Supremacist Terrorists Who Embraced Racist, Antisemitic “Great Replacement Theory”
Digital.com Survey Shows Nearly 50 Percent of Consumers Are Unlikely to Buy from Companies with Opposing Political Views
ATTOM UNVEILS INNOVATIVE CLOUD-BASED PLATFORM OFFERING INSTANT AND DIRECT ACCESS TO ITS DATA
630 Steelworkers Are on Strike At Glencore’s Raglan Mine
Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)

App Coding

web3 iteration of the internet
Amazon MWS Integration from Celigo Now Available on SAP® Store
Code Intelligence raises $12M Series A
Dynamic forms for your React app
Writing code on the fly

API Coding

WSO2 Completes $93 Million Series E Growth Funding Round with the Investment from Info Edge
What is a REST API?
LeadDev London! The event for engineering leaders
One AI to Take on Global Language AI Challenge with NLP-as-a-service Platform for Developers
Fintech AI Leader Photon Commerce Partners With Identifee to Enable Banks to Instantly Digitize and Analyze Statements

Copyright © 2022 3v.org

Technologies, Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT